Pages that link to "Q35180490"

The following pages link to A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy (Q35180490):

Displaying 25 items.

• Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy (Q24187966) (← links)
• A review of anti-VEGF agents for proliferative diabetic retinopathy (Q27025643) (← links)
• Diabetic macular oedema: clinical risk factors and emerging genetic influences. (Q30234323) (← links)
• The outcomes and prognostic factors of vitrectomy in chronic diabetic traction macular detachment (Q30275957) (← links)
• Identification of novel drug targets for the treatment of diabetic retinopathy (Q31134280) (← links)
• New Therapeutic Approaches in Diabetic Retinopathy (Q33583037) (← links)
• Multicolor pattern scan laser for diabetic retinopathy with cataract (Q34063072) (← links)
• Ocular pharmacokinetics of bevacizumab in vitrectomized eyes with silicone oil tamponade (Q36154521) (← links)
• Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy (Q37053882) (← links)
• Bevacizumab as an adjunct to vitreoretinal surgery for diabetic retinopathy in East Africa (Q37317228) (← links)
• Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population (Q37477129) (← links)
• AGEs, RAGE, and Diabetic Retinopathy (Q37876790) (← links)
• Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab (Q37997307) (← links)
• Surgical treatment for diabetic vitreoretinal diseases: a review (Q38793330) (← links)
• Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab (Q40196662) (← links)
• Improving care and increasing efficiency-challenges in the care of chronic eye diseases. (Q42733207) (← links)
• Intraocular surgery in a large diabetes patient population: risk factors and surgical results (Q44920544) (← links)
• Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials (Q47300238) (← links)
• Ranibizumab pretreatment in diabetic vitrectomy: a pilot randomised controlled trial (the RaDiVit study). (Q51006402) (← links)
• Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline. (Q54942391) (← links)
• Lymphatic Vascular Structures: A New Aspect in Proliferative Diabetic Retinopathy (Q60956883) (← links)
• A Systematic Review and Meta-Analysis of Clinical Outcomes of Intravitreal Anti-VEGF Agent Treatment Immediately after Cataract Surgery for Patients with Diabetic Retinopathy (Q64241079) (← links)
• [The role of the vitreous body in diseases of neighboring structures] (Q85527739) (← links)
• Macular morphologic findings on optical coherence tomography after microincision vitrectomy for proliferative diabetic retinopathy (Q87273692) (← links)
• Frequency and Risk Factors for Neovascular Glaucoma After Vitrectomy in Eyes with Diabetic Retinopathy: An Observational Study (Q92011509) (← links)